Skip to main content
. 2019 Nov 28;34(9):e201900905. doi: 10.1590/s0102-865020190090000005

Table 3. Pain conditions of different groups of patients by VAS scores and PCIA pressing times.

Variables Time points Parecoxib Dexmedetomidine Combined Control
VAS 4 h 3.7±1.7c,d 3.9±1.3c,d 2.4±1.0a,b,d 5.8±2.3a,b,c
12 h 2.9±0.9c,d 3.0±1.2c,d 1.8±0.4a,b,d 4.6±1.7a,b,c
24 h 1.9±0.2c,d 2.1±0.6c,d 1.4±0.1a,b,d 2.8±0.8a,b,c
48 h 1.1±0.1d 1.0±0.1d 1.1±0.1 d 1.2±0.1a,b,c
PCIA 48 h 5.0±1.3c,d 5.1±1.9c,d 3.4±1.4a,b,d 7.8±2.3a,b,c
a

P<0.05, compared with the Parecoxib group;

b

P<0.05, compared with DEX group;

c

P<0.05, compared with Combined group;

d

P<0.05, compared with Control group.

VAS Visual Analogue Score, PICA patient-controlled intravenous analgesia pump.